Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03811002
Title Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lung small cell carcinoma


Atezolizumab + Carboplatin + Etoposide

Atezolizumab + Cisplatin + Etoposide

Cisplatin + Etoposide

Carboplatin + Etoposide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.